Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Residual Leaks After LAA Closure: Surveillance, Diagnosis, and Treatment (With Cases)

Presenter: Robert J. Sommer, Brian K. Whisenant

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Pericardial Effusions and Tamponade After LAA Closure: Frequency, Mechanisms, and Treatment (With Cases)

Presenter: Robert J. Sommer, Brian K. Whisenant, Saibal Kar

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Anatomically Correct JenaValve TAVR System: AS and Pure AR Treatment

Presenter: Torsten P. Vahl

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Clinical Experience With Hybrid Transcatheter Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Presenter: Patrick Klein

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Structural Heart Intervention Trifecta: Contemporaneous Transseptal Valve in Mitral Ring, Paravalvular Leak, and Amplatzer Septal Defect Closure for the Treatment of Severe Symptomatic Mitral Regurgitation

Presenter: A. Pieter Kappetein, Dee Dee Wang, Lowie Van Assche, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TR Repair vs Replacement Strategies: Lessons From Surgery

Presenter: Georg Nickenig, Stephan Windecker, Gilbert H.L. Tang

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

When Should the Tricuspid Valve Be Repaired During Mitral Valve Surgery?

Presenter: Georg Nickenig, Stephan Windecker, Steven F. Bolling

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TR Due to Pacemaker Lead Entrapment: Frequency, Diagnosis, Clinical Consequencs, and Treatment Alternatives

Presenter: Georg Nickenig, Stephan Windecker, Neil P. Fam

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Presenter: Georg Nickenig, Stephan Windecker, Ori Ben-Yehuda

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Presenter: Susheel K. Kodali, Michael J. Reardon, Patrick M. McCarthy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Presenter: Susheel K. Kodali, Michael J. Reardon, Mathew Williams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Goal of FMR Treatment: Reduction or Elimination of MR?

Presenter: Randall C. Starling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Many Faces of MAC: Imaging Patterns, Associated Mitral Valve Pathologies, and Treatment Strategies

Presenter: Mayra Guerrero, Vinod H. Thourani, Vinayak Bapat

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Advertisement

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Residual Leaks After LAA Closure: Surveillance, Diagnosis, and Treatment (With Cases)

Pericardial Effusions and Tamponade After LAA Closure: Frequency, Mechanisms, and Treatment (With Cases)

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

The Anatomically Correct JenaValve TAVR System: AS and Pure AR Treatment

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Early Clinical Experience With Hybrid Transcatheter Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Structural Heart Intervention Trifecta: Contemporaneous Transseptal Valve in Mitral Ring, Paravalvular Leak, and Amplatzer Septal Defect Closure for the Treatment of Severe Symptomatic Mitral Regurgitation

TR Repair vs Replacement Strategies: Lessons From Surgery

When Should the Tricuspid Valve Be Repaired During Mitral Valve Surgery?

TR Due to Pacemaker Lead Entrapment: Frequency, Diagnosis, Clinical Consequencs, and Treatment Alternatives

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

The Goal of FMR Treatment: Reduction or Elimination of MR?

The Many Faces of MAC: Imaging Patterns, Associated Mitral Valve Pathologies, and Treatment Strategies

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content